How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

calendar_today October 10, 2025 person hollywindler domain field-medical

CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ – Field Medical, Inc.